Masimo gets FDA clearance for opioid respiratory risk detection
Masimo, a Danaher company, has received FDA 510(k) clearance for an opioid-induced respiratory depression (OIRD) detection capability integrated into its ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
